FAPI PET versus FDG PET, CT or MRI for Staging Pancreatic-, Gastric- and Cholangiocarcinoma: Systematic Review and Head-to-Head Comparisons of Diagnostic Performances
暂无分享,去创建一个
K. Pieterman | F. Verburg | B. Wijnhoven | B. Groot Koerkamp | I. Pruis | M. Thomeer | S. V. V. Veldhuijzen van Zanten | L. V. van Driel
[1] X. Lan,et al. 68Ga-DOTA-FAPI-04 PET/MR in the Evaluation of Gastric Carcinomas: Comparison with 18F-FDG PET/CT , 2021, The Journal of Nuclear Medicine.
[2] F. Daams,et al. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC). , 2021, JAMA surgery.
[3] Ping Guo,et al. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[4] P. Choyke,et al. FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis? , 2021, Cancers.
[5] Zan-yi Wu,et al. Intense [68Ga]Ga-FAPI-04 uptake in solitary fibrous tumor/hemangiopericytoma of the central nervous system , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[6] G. Lahat,et al. Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[7] C. Gündoğan,et al. 68Ga-FAPI Uptake of Thyroiditis in a Patient With Breast Cancer. , 2021, Clinical nuclear medicine.
[8] Shaobo Yao,et al. Increased 68Ga-FAPI-04 Uptake in Schmorl Node in a Patient With Gastric Cancer. , 2021, Clinical nuclear medicine.
[9] Wei Zhang,et al. Elevated 68Ga-FAPI Activity in Splenic Hemangioma and Pneumonia. , 2021, Clinical nuclear medicine.
[10] Xiao Yang,et al. Increased 68Ga-FAPI Uptake in Chronic Cholecystitis and Degenerative Osteophyte. , 2021, Clinical nuclear medicine.
[11] X. Lan,et al. Non-malignant findings of focal 68Ga-FAPI-04 uptake in pancreas , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[12] Hua Wu,et al. Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[13] D. Jäger,et al. Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas , 2020, The Journal of Nuclear Medicine.
[14] R. Tothill,et al. FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology? , 2020, The Journal of Nuclear Medicine.
[15] Hua Wu,et al. Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers. , 2020, Radiology.
[16] Ping Guo,et al. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[17] Haitao Zhao,et al. Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[18] Hua Wu,et al. Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[19] Haitao Zhao,et al. Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[20] Frederik L. Giesel,et al. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer , 2019, The Journal of Nuclear Medicine.
[21] Frederik L. Giesel,et al. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers , 2018, The Journal of Nuclear Medicine.
[22] K. Conlon,et al. The Role of Staging Laparoscopy in Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis , 2018, Digestive Surgery.
[23] David Moher,et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement , 2018, JAMA.
[24] Spyridon N Papageorgiou,et al. Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. , 2018, Journal of clinical epidemiology.
[25] G. Poston,et al. Role of staging laparoscopy in the stratification of patients with perihilar cholangiocarcinoma , 2017, The British journal of surgery.
[26] Susan Mallett,et al. Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles , 2014, PloS one.